Also trades as: VM.V (TSXV) · $vol 0M
VYYRF OTC
Voyageur Pharmaceuticals Ltd.
1W: -7.4%
1M: -19.4%
3M: +5.3%
YTD: -23.1%
1Y: -16.7%
3Y: +94.2%
5Y: +149.4%
$0.10
+0.00 (+0.00%)
Weekly Expected Move ±581.3%
$-1
$-0
$0
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$12K
+0.0% ▲
Gross Profit
-$1M
+0.0% ▲
Operating Income
-$4M
-233109.6% ▼
Net Income
-$4M
-206605.4% ▼
EPS (Diluted)
$-0.02
-71.0% ▼
EBITDA
-$4M
-233034.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $12K |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $2K | $3K | $2K | $0 | $1M |
| Gross Profit | -$2K | -$3K | -$2K | $0 | -$1M |
| Gross Margin | — | — | — | — | -10466.9% |
| R&D Expenses | $497K | $528K | $0 | $0 | $907K |
| SG&A Expenses | $2M | $1M | $1M | $2K | $1M |
| Operating Expenses | $2M | $2M | $1M | $2K | $2M |
| Operating Income | -$2M | -$2M | -$1M | -$2K | -$4M |
| Operating Margin | — | — | — | — | -30232.7% |
| Interest Expense | $3K | $0 | $0 | $0 | $0 |
| Income Before Tax | -$2M | -$2M | -$1M | -$2K | -$4M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$2M | -$2M | -$1M | -$2K | -$4M |
| Net Margin | — | — | — | — | -30232.7% |
| EPS (Diluted) | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.02 |
| EBITDA | -$2M | -$2M | -$1M | -$2K | -$4M |
| Shares Outstanding | 95M | 108M | 131M | 137626 | 166M |